Pulsenmore (PLSM) Liabilities and Shareholders Equity (2025)

Pulsenmore (PLSM) posted Liabilities and Shareholders Equity of $31.9 million for Q4 2025.

Pulsenmore (PLSM) Liabilities and Shareholders Equity (2025) Analysis & Trends

Pulsenmore has reported Liabilities and Shareholders Equity for 1 years, with the latest figure at $31.9 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Liabilities and Shareholders Equity (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	109.22 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	47.93 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	93.03 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	45.22 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	13.87 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	6.46 Bn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	37.25 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	31.04 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	10.74 Bn
10	Pulsenmore	18.62 Mn	-3.05 Mn	-	31.93 Mn

Download Data

Date	Value
Dec 31, 2025	31.93 Mn